Information:
Fel:
ID
21190
Beskrivning
Evaluation of Rapid Virologic Response Among HCV Patients Treated With PegIntron and Rebetol in Brazil (Study P05427); ODM derived from: https://clinicaltrials.gov/show/NCT00724854
Länk
https://clinicaltrials.gov/show/NCT00724854
Nyckelord
Versioner (1)
- 2017-04-12 2017-04-12 -
Uppladdad den
12 april 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Hepatitis C, Chronic NCT00724854
Eligibility Hepatitis C, Chronic NCT00724854
- StudyEvent: Eligibility
Similar models
Eligibility Hepatitis C, Chronic NCT00724854
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Study participation status and informed consent
Item
willing to participate in the study and sign the informed consent form
boolean
C2348568 (UMLS CUI [1])
C0021430 (UMLS CUI [2])
C0021430 (UMLS CUI [2])
HCV PCR
Item
established hcv infection, confirmed by molecular biology test (positive qualitative polymerase chain reaction [pcr] test)
boolean
C0220847 (UMLS CUI [1,1])
C0032520 (UMLS CUI [1,2])
C0032520 (UMLS CUI [1,2])
Treatment, HIV coinfection
Item
can be treatment-naïve, have retreatment, or co-infected with hiv
boolean
C0087111 (UMLS CUI [1])
C4062778 (UMLS CUI [2])
C4062778 (UMLS CUI [2])
Pegintron and Ribavirin
Item
be under treatment with pegintron in combination with ribavirin, starting up to 14 days before the screening visit
boolean
C1527737 (UMLS CUI [1,1])
C0035525 (UMLS CUI [1,2])
C0035525 (UMLS CUI [1,2])
Study participation status
Item
participants who have not confirmed their willingness to participate in the study or have refused to sign the free and informed consent form
boolean
C2348568 (UMLS CUI [1])
Prior treatment with pegintron
Item
prior treatment with pegintron (combined with ribavirin or not)
boolean
C1514463 (UMLS CUI [1,1])
C1527737 (UMLS CUI [1,2])
C1527737 (UMLS CUI [1,2])
Substance Use Disorder
Item
history of alcohol abuse in the past 6 months
boolean
C0038586 (UMLS CUI [1])
Liver disease
Item
decompensated liver disease
boolean
C0023895 (UMLS CUI [1])
Heart disease
Item
severe heart disease
boolean
C0018799 (UMLS CUI [1])
Thyroid disorder
Item
decompensated thyroid disorder
boolean
C0040128 (UMLS CUI [1])
Neoplasia
Item
neoplasia
boolean
C1882062 (UMLS CUI [1])
Diabetes mellitus type 1
Item
type 1 diabetes mellitus - uncontrolled or hardly controlled
boolean
C0011854 (UMLS CUI [1])
Seizures
Item
seizures - uncontrolled
boolean
C0036572 (UMLS CUI [1])
Primary immune deficiency
Item
primary immune deficiency
boolean
C0398686 (UMLS CUI [1])
Contraceptive methods
Item
men and women not using appropriate contraceptive methods
boolean
C0700589 (UMLS CUI [1])
Gynaecological status
Item
pregnancy or lactation
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
HIV Coinfection: HIV-related opportunistic disease or CD4 count
Item
for participants co-infected with hiv: hiv-related opportunistic disease in the past 6 months or cd4 count lower than 200 cells/mm^3
boolean
C4062778 (UMLS CUI [1])
C0162526 (UMLS CUI [2])
C0243009 (UMLS CUI [3])
C0162526 (UMLS CUI [2])
C0243009 (UMLS CUI [3])